Panagora Asset Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-112,829
| Closed | -$1.73M | – | 1233 |
|
|
2024
Q3 | $1.73M | Sell |
112,829
-132,778
| -54% | -$2.03M | 0.01% | 566 |
|
|
2024
Q2 | $3.74M | Sell |
245,607
-144,692
| -37% | -$2.2M | 0.02% | 374 |
|
|
2024
Q1 | $7.37M | Buy |
390,299
+161,303
| +70% | +$3.05M | 0.04% | 277 |
|
|
2023
Q4 | $4.37M | Buy |
228,996
+129,697
| +131% | +$2.48M | 0.02% | 340 |
|
|
2023
Q3 | $1.78M | Buy |
99,299
+2,107
| +2% | +$37.8K | 0.01% | 562 |
|
|
2023
Q2 | $1.97M | Sell |
97,192
-155,792
| -62% | -$3.16M | 0.01% | 543 |
|
|
2023
Q1 | $4.61M | Buy |
252,984
+55,384
| +28% | +$1.01M | 0.03% | 382 |
|
|
2022
Q4 | $4.09M | Buy |
197,600
+13,466
| +7% | +$278K | 0.03% | 424 |
|
|
2022
Q3 | $4.82M | Buy |
184,134
+6,120
| +3% | +$160K | 0.03% | 368 |
|
|
2022
Q2 | $4.51M | Buy |
178,014
+13,711
| +8% | +$347K | 0.03% | 406 |
|
|
2022
Q1 | $5.19M | Buy |
164,303
+8,684
| +6% | +$274K | 0.03% | 409 |
|
|
2021
Q4 | $6.3M | Sell |
155,619
-30,559
| -16% | -$1.24M | 0.03% | 369 |
|
|
2021
Q3 | $6.49M | Sell |
186,178
-3,276
| -2% | -$114K | 0.03% | 378 |
|
|
2021
Q2 | $5.2M | Sell |
189,454
-2,696
| -1% | -$74K | 0.03% | 440 |
|
|
2021
Q1 | $5.4M | Buy |
192,150
+47,363
| +33% | +$1.33M | 0.03% | 447 |
|
|
2020
Q4 | $3.76M | Sell |
144,787
-3,217
| -2% | -$83.5K | 0.02% | 498 |
|
|
2020
Q3 | $2.54M | Sell |
148,004
-18,885
| -11% | -$324K | 0.02% | 556 |
|
|
2020
Q2 | $4.13M | Buy |
166,889
+122,703
| +278% | +$3.04M | 0.03% | 453 |
|
|
2020
Q1 | $613K | Buy |
44,186
+42,475
| +2,482% | +$589K | ﹤0.01% | 1030 |
|
|
2019
Q4 | $17K | Buy |
1,711
+352
| +26% | +$3.5K | ﹤0.01% | 2064 |
|
|
2019
Q3 | $12K | Sell |
1,359
-67
| -5% | -$592 | ﹤0.01% | 2151 |
|
|
2019
Q2 | $11K | Buy |
+1,426
| New | +$11K | ﹤0.01% | 2388 |
|